All In MedTech

Company

Venclose

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$27.1M

1 Form D offering, 2019 to 2019

Equity

$27.1M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $27.1M raised of $27.1M sought, first sale Jul 3, 2019, 67 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jul 3, 2019Equity$27.1M$27.1M67Rule 506(b)Form D/A ↗Nov 29, 20191 amendment

Company details

From the company's latest Form D.

Legal name
Venclose, Inc.
Headquarters
San Jose, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    5 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Venclose.

    Latest FDA decisions

    Search the Clearance Tracker

    1 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    Reports received

    103

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    62

    60% of reports

    Injury reports

    41

    40% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 240000
    Feb 242000
    Mar 242110
    Apr 241200
    May 245000
    Jun 243000
    Jul 244200
    Aug 241000
    Sep 241400
    Oct 242000
    Nov 246400
    Dec 240400
    Jan 254100
    Feb 250100
    Mar 257400
    Apr 253000
    May 254100
    Jun 253200
    Jul 251300
    Aug 250000
    Sep 251100
    Oct 2519300
    Nov 250000
    Dec 2531000
    Jan 2603000
    Feb 264000
    Mar 265000
    Apr 263000
    May 262700
    Jun 262000
    Jul 264200
    Aug 263100
    Sep 268000
    Oct 260100
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.